Ipilimumab vs Methylene Blue Cation
Ipilimumab vs Methylene Blue Cation: Overview
This comparison examines the pharmacological differences between Ipilimumab and Methylene Blue Cation.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days.
Chemical Properties
Type: Ipilimumab — Antibody; Methylene Blue Cation — Small molecule.